"The latest results from a small, early stage trial of Pharmacyclics Inc's experimental drug for non-Hodgkin's lymphoma showed about 49 percent of patients responded to it, the company said on Saturday."Read the full story here.
Monday, June 27, 2011
Pharmacyclics lymphoma drug shows continued promise
Reuters reports that:
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment